Real-time enrollment status for this solid tumor clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 11:54 PM UTC
| NCT Number | NCT06619587 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 410 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Genentech, Inc. |
| Last Updated on CT.gov | September 23, 2026 (2 weeks ago) |
As of October 13, 2026: Clinical trial NCT06619587 is currently recruiting participants. This phase1 study for solid tumor is actively seeking new participants at 12 locations across the United States. The study is sponsored by Genentech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06619587 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06619587 was last updated 2 weeks ago (September 23, 2026). HelloStudys verifies this status automatically.